PHOENIX -- Alliance Medical Corporation, a leading reprocessor of single-use medical devices (SUDs),
announced today the appointment of two new members to the company's board of
directors: John B. Grotting, former chairman, president and CEO of Bridge
Medical Incorporated; and Matthew P. Marshall, former senior vice president,
HBOC Division of McKesson Corporation.
"The addition of John and Matthew to our board will bring fresh perspectives
that will enhance Alliance's strategic positioning, new partnership
opportunities and product-line expansions," says Alliance CEO Rick Ferreira.
"Their combined industry knowledge, expertise and relationships in the
medical device industry are valuable assets for Alliance, its customers and
the reprocessing industry at large. We are confident that they will assist
us in further promoting the concept, benefits and safety of medical device
reprocessing and its ability to help hospitals save significant dollars that
can be re-allocated to improving patient care."
Grotting has most recently served as chairman, president and CEO of Bridge
Medical Inc., a software and IT company focused on eliminating preventable
medication, lab specimen and blood transfusion errors in hospitals. At
Bridge Medical, Grotting prompted a financial turnaround after successfully
raising more than $55 million in venture capital; repositioned the company;
recruited a new, extremely effective management team and board of directors;
and established five strategic corporate partnerships. Previously, Grotting
served in top management positions at several prestigious healthcare
organizations, including Allina Health Systems, systems VP; HealthSpan
Corporation, operations officer; Health One Corporation, executive VP and
COO; Legacy Health System, acting president/CEO; and HealthLink, president
and CEO.
With a notable 17-year career in the healthcare industry prior to his recent
retirement, Marshall most currently served as senior vice president at the
HBOC Division of McKesson Corporation, a leading healthcare supply
management and information solutions company. He was responsible for a team
of 12 vice presidents, 27 managers, and more than 500 sales and sales
support employees. Under his leadership, in 2001, his division generated
$108 million in new software sales, a 95 percent increase over the previous
year, as well as the overachievement of the 2002 sales plan, through Q2,
with $152 million in new software sales.
Alliance Medical Corporation is a leading reprocessor of specific single-use
medical devices (SUDs). Alliance has safely reprocessed more than 7 million
SUDs, saving hospitals and surgery centers in excess of $100 million. The
company's services focus on reducing supply chain costs of hospitals and
surgery centers suffering from shrinking reimbursements and increasing
costs. Alliance's unique AIM (Assessment, Implementation and Management)
program uses clinical implementation teams to provide facilities with the
tools needed to maximize their savings from reprocessing.
Source: Alliance Medical Corporation
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
The Importance of Hand Hygiene in Clostridioides difficile Reduction
November 18th 2024Clostridioides difficile infections burden US healthcare. Electronic Hand Hygiene Monitoring (EHHMS) systems remind for soap and water. This study evaluates EHHMS effectiveness by comparing C difficile cases in 10 hospitals with CMS data, linking EHHMS use to reduced cases.